Ultrastructural investigation of epithelial damage in asthmatic and non-asthmatic nasal polyps  by Shahana, S. et al.
Respiratory Medicine (2006) 100, 2018–2028
Ultrastructural investigation of epithelial damage
in asthmatic and non-asthmatic nasal polyps
S. Shahanaa, Z. Jaunmuktanea, M. Stenkvist Asplundb, G.M. Roomansa,
aDepartment of Medical Cell Biology, University of Uppsala, Box 571, 75123 Uppsala, Sweden
bEar Nose and Throat Clinic, Academic Hospital, 75185 Uppsala, Sweden
Received 9 June 2005; accepted 12 February 2006
KEYWORDS
Nasal polyposis;
Asthma;
Epithelial damage;
Desmosomes;
Eosinophils
Summary Nasal polyposis is a poorly understood chronic inflammatory disease
often associated with asthma. As nasal polyps and asthma both are associated with
massive eosinophil infiltration, they may share a common pathophysiological
mechanism. Many genetic and autoimmune diseases may result from altered
expression or function of cell adhesion molecules such as desmosomes. A
transmission electron microscopical study was carried out on tissue from 15 patients
suffering from nasal polyps, to investigate if there are changes in desmosomes in
nasal polyps from asthmatic and/or allergic patients versus non-asthmatic versus
non-allergic patients. In allergic patients the damage to columnar cells was more
extensive than in non-allergic patients. Massive infiltration of eosinophils was
observed in epithelium and connective tissue in all groups. No significant difference
in thickness of the basal lamina was found between any of the groups. All patients
had dilated capillaries in the connective tissue. The intercellular space between the
epithelial cells was smallest in the asthmatic non-allergic group. The relative length
of columnar cell or basal cell desmosomes was reduced in patients with asthma or
allergy, compared to non-allergic, non-asthmatic patients. Hence, there appears to
be a weakness in the desmosomes in asthmatics and allergics. Epithelial shedding
may play an important role in the pathophysiological process of a multifactorial
disease such as asthma.
& 2006 Elsevier Ltd. All rights reserved.
Introduction
Nasal polyps commonly arise from the paranasal
sinuses, and are characterized by infiltration of the
mucosa by eosinophils, lymphocytes and mast cells,
and also by a variable degree of epithelial
damage.1 The frequency of nasal polyps is 1–4%,2
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and the disease is often coupled to aspirin intoler-
ance, asthma or cystic fibrosis (CF).3 Many cases of
nasal polyps do not give symptoms but can be
detected at autopsy4; hence the frequency of
polyps may be higher than is apparent from clinical
studies.
Nasal polyps have long been associated with
rhinitis and asthma. However, the role of allergy in
the aetiology and pathogenesis of nasal polyps is a
controversial issue. The prime histological feature
of nasal polyps is massive infiltration of eosino-
phils.5,6 The number of eosinophils, neutrophils,
and plasma cells in nasal polyps is significantly
higher than in the nasal mucosa. Eosinophilic cation
protein (EG2+) cells, which are activated eosino-
phils, are also seen frequently. Elevation of the
number of these cells suggests the role of inflam-
matory processes in the pathophysiology of nasal
polyps.7 The endothelium plays a critical role in
inflammation by directing circulating leukocytes
into extravascular tissues by expressing adhesive
molecules such as ICAM-1. Corticosteroid treatment
in patients with nasal polyps does not reduce ICAM-
1 to that of turbinate tissue.7 An increased number
of cells producing IL-4, IL-5, IFN-gamma, IL-12 and
TGF-beta have been found in nasal polyps.1 The
cytokine pattern shows neither Th1 nor Th2
predominance: both Th1 and Th2 cytokines are
upregulated in nasal polyp tissue independently of
the atopy status).8,9 High levels of mast cells have
been found in nasal polyps,10 but these were not
related to allergy.11 There is no certain relationship
between nasal polyps and allergy, despite the
presence of eosinophils.2 Mostly, nasal polyps were
associated with non-allergic rhinitis or non-allergic
asthma.12 There could be a systemic connection
between upper airway disease (rhinitis, nasal
polyps) and lower airway disease (asthma).13
Epithelial damage in nasal polyps was first
demonstrated by Wladislavosky-Wasserman et al.14
Epithelial damage improved after intranasal bude-
sonide.1 Squamous metaplasia has also been noted
in polyps.15 Increased epithelial cell proliferation
was demonstrated by Coste et al.16 In another
recent study, all nasal polyps showed focal edema,
hyperplasia, atrophy, or squamous metaplasia of
the epithelium. The lamina propria was moderately
populated with small blood vessels and mucous
glands and showed focal accumulation of inflam-
matory cells.17
Amin et al.18 demonstrated a correlation be-
tween inflammatory cells and epithelial damage in
bronchial biopsies of asthmatics. Shahana et al.19
demonstrated that desmosomes were affected in
allergic and non-allergic asthma. Substances pro-
duced by inflammatory cells may affect cell
contacts.20,21 The epithelial cell–cell adhesion
involves primarily desmosomes. The airway mucosa
has to maintain tight cell–cell adhesion to protect
the airway from external noxious substances. The
importance of cell adhesion molecules is demon-
strated by the large number of genetic and
autoimmune diseases that result from altered
expression or function of these structures.22
In the present study we wanted to study
epithelial damage in nasal polyps with special
attention to desmosomes. A comparison was car-
ried out between nasal polyps from patients with
and without asthma or with and without allergy.
Materials and methods
Patients
Nasal polyps were taken from 15 adults, 6 of them
asthmatics, of which 3 were allergic and 3 non-
allergic; 2 adults were suffering from allergy but
not from asthma, and the remaining 7 had neither
allergy nor asthma (Table 1). Allergy had previously
been documented by either skin test or blood
sample (Phadiatop, Pharmacia Diagnostics, Uppsa-
la, Sweden). Clinically diagnosed patients with
nasal polyps were being followed up at the
Department of Ear Nose and Throat Diseases at
Uppsala Academic Hospital. All patients had
chronic nasal congestion, chronic rhinorrhea and
all except one variable degrees of anosmia. One of
the patients in the no allergy/no asthma group was
a smoker. None of the subjects suffered from
respiratory infection during surgery. Out of 15
patients 2 were female and 13 male. Seven of the
patients had had no previous surgery. All patients
except one were using nasal steroids (3 patients
flutikason proprionate, 6 patients mometasone-
furoate, 4 patients budenoside, and 1 patient
several of these drugs) and all patients except
two were periodically using oral cortisone tablets;
the exceptions were due to advanced age and
stomach problems, respectively. Treatment with
corticosteroids had not been suspended prior to
surgery. Polyps were removed during functional
endoscopic sinus surgery (FESS) from ethmoidal
cells and meatus medius bilaterally, immediately
examined macroscopically and fixed in glutaralde-
hyde for electron microscopy.
Specimen preparation
Small pieces of the polyps were fixed in 2.5%
glutaraldehyde in 0.1M sodium cacodylate buffer
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for 1 day. After being washed in cacodylate buffer,
the specimens were post-fixed in 1% OsO4 in
cacodylate buffer for 60min. A second wash in
buffer was followed by dehydration in a graded
series of ethanol, and the tissue pieces were finally
embedded in Agar 100 Resin (Agar Scientific,
Stansted, UK). All specimens were coded and
examined without any knowledge of the diagnosis.
Light microscopy
Sections were cut to 2 mm thickness, stained with
toluidin blue and examined with a Motic 1B light
microscope (Motic, Wetzlar, Germany). Using Motic
Image Plus Software, the length of different types
of epithelium relative to the length of the basal
lamina was determined. The epithelium was di-
vided into the following categories: 1 ¼ normal
epithelium, 2 ¼ goblet cell hyperplasia,
3 ¼ epithelium with several layers of basal and
intermediate cells plus columnar cells,
4 ¼ epithelium with one basal cell layer and
damaged or lacking columnar cells, 5 ¼ several
layers of basal or intermediate cells, but no
columnar cells, 6 ¼ no epithelium, 7 ¼ metaplastic
epithelium.
Transmission electron microscopy (TEM)
Ultrathin sections were cut, contrasted with uranyl
acetate/lead citrate, and examined in a Hitachi H
7100 TEM (Hitachi, Tokyo, Japan) at 75 kV. The
degree of damage was judged by two independent
observers, using a scale of 1–5, where 1 indicates
no damage, 2 ¼ the presence of intracellular
spaces between the cells, 3 ¼ detachment of a
few columnar cells, 4 ¼ detachment of some, but
not all of the columnar cells, and 5 a total loss of
columnar epithelium. To quantify the relative
length of the desmosomes 5–10 columnar and
5–10 basal cells were randomly selected for each
patient for whom these parameters were quanti-
fied. The TEM image was transferred via a digital
camera to a Synopsis (Cambridge, UK) Synapse
frame capture system. The length of all desmo-
somes of a columnar cell, or a basal cell,
respectively, was determined and divided by the
perimeter of the cell. The desmosomal length was
determined at an original magnification of 15000
and the perimeter of the cells was determined at
an original magnification of 2000 . The thickness
of the basal lamina was determined at an original
magnification of 30000 at 10 randomly selected
positions along the basal lamina. The presence of
eosinophils, mast cells, lymphocytes and neutro-
phils was scored qualitatively for each specimen.
Goblet cells were scored quantitatively for each
specimen.
Statistical analysis
Data are shown as mean7standard error. Statistical
analysis was performed using an unpaired Student’s
t-test or the Mann–Whitney U-test when the
distribution of data was not normal. Significance
was attributed to probability values Po0:05.
Results
Qualitative observations
Epithelial damage was commonly observed. Two
independent observers determined the grade of
epithelial damage. In no case did the grading differ
with more than a single step between the ob-
servers. In one case, a patient with neither asthma
nor allergy, metaplastic epithelium was found. The
data for asthmatic patients were compared with
those for non-asthmatic patients (irrespective of
the presence of allergy) and the data for allergic
patients were compared to the data for non-
allergic patients (irrespective of the presence of
asthma). Statistical analysis of the data (Fig. 1)
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Table 1 Patient characteristics.
Astma and allergy Asthma, no allergy Allergy, no asthma Neither asthma nor allergy
Age (yr) 40 (31–64) 67 (58–67) 59 (57–60) 43 (26–61)
Sex (M/F) 3/0 1/2 2/0 7/0
Nasal steroids 3/3 2/3 2/2 7/7
Cortison tablets 3/3 2/3 2/2 5/7
Previous surgery 0.67 (0–2) 0.67 (0–2) 2.5 (2–3) 1.71 (0–5)
Smell 0.67 (0–2) 1.67 (0–3) 1 (1–1) 0.86 (0–2)
Definition of abbreviations: yr ¼ year; M ¼ male; F ¼ female; Smell 0 ¼ no smell, 1 ¼ poor, 2 ¼ sometimes problems, 3 ¼
good condition.
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showed no significant difference between any of
the groups.
The presence of inflammatory cells was deter-
mined in a semi-quantitative manner (Table 2). The
data in this table are divided into three groups: (1)
neither allergy nor asthma, (2) allergy (but no
asthma), and (3) asthma (allergic and non-allergic).
The allergic, but-non-asthmatic, patients have the
lowest frequency of eosinophils and neutrophils.
Some patients showed massive infiltration of
leukocytes, in particular eosinophils, in the epithe-
lium (Fig. 2). Only few eosinophils showed signs of
apoptosis, most eosinophils appeared to undergo
piece-meal degranulation. All patients had dilated
capillaries in the connective tissue, which was
oedematous. In some patients, it was noted that
leukocytes were migrating out of the capillaries
(Fig. 3). In a few samples, plasma cells were
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Table 2 Qualitative electron microscope observations.
Eos epi Neutro epi Eos CT Neutr CT Lympho Mast cell Dilated vessel
& edema
Goblet
cell (%)
PC
Asthma and allergy
2    + + ++ +  
11 + + +++ ++ ++ + + 71 +
15   ++ + + + ++  
Asthma, no allergy
1 + + ++ ++ + + + 54 
5   + +++ +++ + +  
12 ++++ ++ + + + + + 62 
No asthma, allergy
4 +  + + + + +  
8   + ++ ++  +  
Neither asthma nor allergy
3     + + +  
6   +++ ++ + + +  +
7 +  +++ + + + +  
9 ++ ++ +++ + ++ + +  
10 +  ++ + +  + 59 
13 +++  ++ + + + + 61 
14 +++  +++  + + + 75 
Eos ¼ eosinophils, Neutro ¼ neutrophils, Lympho ¼ lymphocytes, PC ¼ plasma cells; epi ¼ located in the epithelium,
CT ¼ located in the connective tissue.
Figure 2 Transmission electron micrograph of a polyp
from a patient with asthma showing infiltration of
eosinophils (E) into the epithelium. B: basal cells,
CT: connective tissue. Bar ¼ 5 mm.
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Figure 1 Semiquantitative determination of epithelial
damage (ED). The damage was scored using a scale from 1
to 5 where 1 indicated minimal damage and 5 maximal
damage (see Materials and Methods). The patients were
divided into asthmatics vs. non-asthmatics and allergics
vs. non-allergics. The data show mean and standard
error.
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observed. The number of goblet cells relative to
the total number of columnar cells was determined
in those specimens showing goblet cell hyperplasia.
The limit for goblet cell hyperplasia is 30–40%.
Normal human airway epithelium has a ratio of
approximately three to five ciliated cells to each
goblet cells23,24 with a maximum reported ratio of
ten to one.25
Quantitative analysis
The epithelium was characterized by light micro-
scopy (Fig. 4) and divided into several types.
Comparisons were made between the four groups:
asthma and allergy, asthma/no allergy, allergy/no
asthma, and neither asthma nor allergy (Fig. 5). No
significant differences were found between any of
the groups except for level 4 between allergic and
non-allergic patients, indicating a more extensive
damage of the columnar cells in allergic patients.
The relative length of the desmosomes of the
columnar and basal cells was determined quantita-
tively (Fig. 6). The relative length of columnar cell
desmosomes was significantly smaller in patients
with both asthma and allergy compared to patients
with no asthma or allergy (Fig. 7). The same
tendency was noted for the basal cells (Fig. 8).
No significant difference in thickness of the basal
lamina was found in any of the groups (Fig. 9a, b).
The intercellular space between the epithelial cells
was smallest in the group of asthma/no allergy
patients (Fig. 10a,b).
Discussion
The present study confirmed that epithelial
damage is a characteristic of nasal polyps. The
grade of epithelial damage was determined
and compared between patients with asthma vs.
non-asthmatics and patients with allergy vs. non-
allergics. Damage to the columnar cells was more
extensive in allergic patients. The relative length
of columnar cell desmosomes was significantly
reduced in asthmatics vs. non-asthmatics, and in
allergics vs. non-allergics. For the basal cells,
however, no significant difference between the
groups was noted. Massive infiltration of eosinophils
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Figure 3 Transmission electron micrograph of a polyp
from a patient (neither allergy, nor asthma) showing a
subepithelial capillary (Cap) with leukocytes (L) both
inside and outside (presumably leaving) the blood vessel.
Bar ¼ 10 mm.
Figure 4 Light micrographs of polyp epithelium (a) undamaged, from a patient with neither allergy nor asthma
(bar ¼ 50 mm) (b) damaged, from a patient with asthma (bar ¼ 25 mm). G: submucosal gland.
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was observed in both epithelium and connective
tissue in all groups. No significant difference in
thickness of the basal lamina was found between
any of the groups. All patients had dilated
capillaries in the connective tissue, which was
oedematous.
A previous study from our group has demon-
strated a correlation between the number of
inflammatory cells and epithelial damage in bron-
chial biopsies from patients with asthma.18 Typi-
cally, the columnar cells are lost from the
epithelium, whereas the basal cells remain. The
epithelial cell adhesion in the respiratory epithe-
lium involves primarily desmosomal contacts be-
tween basal cells and columnar cells, since the
attachment of columnar cells to the basal lamina is
very weak in human respiratory epithelia.26 The
integrity of the airway mucosa is important because
it protects the airway from external noxious
substances. Shahana et al.19 showed that desmo-
some connections between columnar and basal
cells were smaller in allergic and non-allergic
asthma patients in comparison with healthy con-
trols. Epithelial defects have apparently also been
described in nasal polyps,14 and this agrees with our
results. Also the results of a recent ultrastructural
study by Baju et al.17 where all nasal polyps showed
focal edema, hyperplasia, atrophy, or squamous
metaplasia of the epithelium, are in line with the
data in our study. The epithelial damage is
apparently a general characteristic of polyposis
and not strictly coupled to allergy or asthma, since
there was epithelial damage in all groups. So far,
very little information is available about the
presence of desmosomes in nasal polyps. The
quantitative assay applied in this study provides
important data on the desmosomal contacts be-
tween epithelial cells of nasal polyps. To our
knowledge, this is the first time that this type of
cell contact is objectively quantified in nasal
polyps.
Recent studies have suggested that the airway
epithelium plays an important role in the patho-
genesis of inflammatory airway diseases. Increased
Na+ absorption may be secondary to chronic
inflammation, which is the hallmark of nasal
polyposis. Recent findings indicate that the absorp-
tion of Na+ is altered, not only in polyps from
CF-patients but also in non-CF polyps.27,28 This
suggests that factors leading to the development of
nasal polyposis include pathophysiological changes
in electrolyte and water transport in the surface
epithelium. The present study showed oedema in
the connective tissue in all patients. Also, differ-
ences in the size of intracellular spaces between
groups were noted, but a direct correlation
with asthma or allergy was not possible. In a
recent study, Shebani et al.26 showed increased
intercellular spaces in the epithelium in bronchial
biopsies of asthmatics versus healthy controls.
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Figure 5 Classification of subtypes of epithelium. The changes in epithelial structure were subdivided into 7 levels, and
the relative frequency of occurrence of each level was determined in each biopsy. Level 1: normal epithelium,
2: normal epithelium with goblet cell hyperplasia, 3: normal epithelium but several layers of basal cells, 4: one layer of
basal cells but very damaged or no columnar epithelium, 5: only basal cells in 2–4 layers, 6: no epithelium at all,
7: metaplasia. The graphs represent mean and standard error.
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Changes in the size of the intercellular space may
be related to changes in water transport across the
epithelium.
Substances produced by inflammatory cells may
affect cell contacts.20,21 Tight junctions and ad-
herens junctions in epithelial cells have been shown
to be disturbed in several inflammatory conditions,
not only in respiratory diseases, but also in
intestinal diseases such as Crohn’s disease.29 A
combination of IL-4 and interferon-g reduces
expression of ZO-1 in a respiratory epithelial cell
line.30 In nasal polyp epithelia, ZO-1 was down-
regulated whereas E-cadherin was upregulated
with increasing severity of epithelial remodeling.31
In in vitro experiments, TNF-a was shown to
decrease the expression of b-catenin and g-catenin
in human airway cells, whereas the expression of E-
cadherin was unaffected.32 Coyne et al.33 found
that both TNF-a and interferon-g may affect tight
junction permeability in airway epithelium. The
effect of corticosteroids on tight junction perme-
ability has, so far, mainly been investigated in other
tissues than airway epithelium, e.g., in intestinal
epithelium,34 but it is not unlikely that tight
junctions, and hence epithelial permeability,
in airway epithelia can also be affected by
corticosteroids.
Furthermore, it has been suggested that a fungal
etiology may underlie severe nasal polyposis,
although this notion is still controversial.35,36 As a
possible mechanism by which fungi act on the
respiratory epithelium, it has been suggested
that fungi produce proteases that bind to
protease-activated receptors; this binding would
activate intracellular signalling pathways that
would give rise to multiple responses, including
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Figure 6 Transmission electron micrograph showing a
desmosome (d) between a columnar (C) and a basal (B)
cells and a desmosome (D) between two basal cells. The
desmosome between the basal cells is more electron
dense than that between the columnar cell and the basal
cell. Bar ¼ 0.5 mm.
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Figure 7 Relative length of desmosomes connecting columnar cells to basal cells, in the four groups (asthma and
allergy; allergy-no asthma; asthma-no allergy; asthma and allergy) Data represent mean and standard error, and a
statistically significant difference from the no asthma/no allergy group is indicated by an asterisk (*Po0:05).
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cytokine production and disruption of tight
junctions.37
The prime histological feature of nasal polyps is a
massive infiltration of eosinophils5,6 and eosinophi-
lia is considered to be present in 86% of all nasal
polyps.38 This agrees with our qualitative findings.
Several cytokines (such as IL-5, ECP, or eotaxin)
were found to be overexpressed in nasal polyps.39
Survival factors for eosinophils (IL-3, IL-5, GM-CSF)
have also been identified in nasal polyps.40,41 There
is experimental evidence that cytotoxic proteins
from eosinophils can damage the respiratory
epithelium21,42 and induce bronchial hyperreactiv-
ity in asthma.42
The presence of eosinophils in between the
epithelial cells and the paucity of eosinophils
undergoing apoptosis (despite the fact that most
patients were treated with corticosteroids, which
are supposed to enhance apoptosis in eosinophils) is
in line with the recent proposal by Uller et al.43
that clearance of eosinophils from nasal polyps may
largely occur via non-apoptotic pathways, e.g., by
transepithelial migration to the lumen of the nasal
cavity.
It has recently been suggested that the increased
number of myofibroblasts in the nasal polyps of the
asthma group may be responsible for the extra-
cellular matrix accumulation, polyp formation, and
polyp recurrence, and that eosinophilic cationic
protein, transforming growth factor (TGF) beta,
and myofibroblasts together are involved in the
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Figure 8 Relative length of desmosomes connecting
basal cells, in asthmatics vs. non-asthmatric and allergics
vs. non-allergics. Data represent mean and standard
error.
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Figure 9 (a) Transmission electron micrograph of basal cells (B) in polyp epithelium, showing the basal lamina BL).
E: eosinophil infiltrating the basal cell layer, CT: connective tissue. Bar ¼ 5 mm. (b) Thickness of the basal lamina in the
four patient groups. Data represent mean and standard error.
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mechanism of asthmatic polyp formation.44 Gluco-
corticoids are known to be effective in the
treatment of nasal polyps. Another recent study
has claimed that the clinical efficacy of glucocorti-
coids on nasal polyps may be due to the induction of
apoptosis in both eosinophils and T lymphocytes
that infiltrate nasal polyps, and to down-regulation
of epithelial GM-CSF production, which prolongs
eosinophil survival.45 Steroids also significantly
decreased all cytokine/chemokine levels, but their
impact on Th2 chemokines was of a much greater
magnitude.46 This accumulated evidence supports
an important role for eosinophils in nasal polyposis.
In the present study, all patients had dilated
capillaries in the connective tissue. This finding can
be explained by the results of a study by Cauna
et al.47 where the sensory nerves and the auto-
nomic vasomotor and secretory nerves invariably
found in normal and abnormal nasal mucosa could
not be identified within the stroma of polyps. This
led to the assumption that denervation of nasal
polyps causes a decrease in secretory activity of the
glands and induces an abnormal vascular perme-
ability, leading to an irreversible tissue oedema.
Nasal polyps develop in areas where the lining of
the nasal cavity joins that of the sinuses, and these
marginal zones contain thin nerve fascicles47 which
may be more sensitive to damage from, for
example, eosinophil-derived proteins.48,49 The
pathogenesis of nasal polyp formation is still
controversial. The present study supports the
multifactorial pathways theory of nasal polyp
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Figure 10 (a) Transmission electron micrograph of basal cells in polyp epithelium, showing the intercellular spaces.
Bar ¼ 5mm. (b) Relative volume of intercellular spaces between basal cells in asthmatics vs. non-asthmatic and
allergics vs. non-allergics. Data represent mean and standard error, and a statistically significant difference from the no
asthma/no allergy group is indicated by an asterisk (**Po0:01).
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formation50 where reduced desmosomal contact
induced by products secreted by inflammatory
cells, in particular eosinophils, may play an
important role in the pathogenesis process.
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